Paper8940066
Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells.
Datta K and 3 others. J Biol Chem, 1996. Cited by 251 papers, by iCite.
Cite this record
ConductScience Library. Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells. Papers, record 8940066. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8940066
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Growth Substances | Major topic |
| Oncogene Protein p21(ras) | Major topic |
| Oncogene Protein pp60(v-src) | Major topic |
| Phosphotransferases (Alcohol Group Acceptor) | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Proto-Oncogene Proteins | Major topic |
| 3T3 Cells | |
| Animals | |
| Cell Line | |
| Enzyme Activation | |
| Mice | |
| Phosphatidylinositol 3-Kinases | |
| Proto-Oncogene Proteins c-akt | |
| Recombinant Proteins | |
| Signal Transduction | |
| Spodoptera | |
| Structure-Activity Relationship |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA06927 | NCI NIH HHS | United States | P01CA006927 | PubMed and NIH | NIH RePORTER |
| CA57436 | NCI NIH HHS | United States | R01CA057436 | PubMed and NIH | NIH RePORTER |
| P30CA006927 | NIH | NIH RePORTER |
Cited by78
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 251 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41883440 | Deciphering the interplay between hypoxia, angiogenesis, and endoplasmic reticulum stress in carcinogenesis: A narrative review. | World J Exp Med | 2026 | https://conductscience.org/library/papers/41883440 | PubMed |
| 41878265 | An exhaustive cell-based screen coupled with an intracellular-induced lux-based reporter identified bioactive molecules that inhibit host cell infection by intracellular pathogens. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/41878265 | PubMed |
| 33916261 | A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal Cancer. | J Pers Med | 2021 | https://conductscience.org/library/papers/33916261 | PubMed |
| 32537260 | Development of human prostate cancer stem cells involves epigenomic alteration and PI3K/AKT pathway activation. | Exp Hematol Oncol | 2020 | https://conductscience.org/library/papers/32537260 | PubMed |
| 31070059 | The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. | Expert Opin Drug Discov | 2019 | https://conductscience.org/library/papers/31070059 | PubMed |
| 30188734 | Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application. | J Med Chem | 2019 | https://conductscience.org/library/papers/30188734 | PubMed |
| 29859871 | Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease. | Neurobiol Dis | 2018 | https://conductscience.org/library/papers/29859871 | PubMed |
| 29799306 | Preclinical evaluation of novel PI3K/mTOR dual inhibitor SN202 as potential anti-renal cancer agent. | Cancer Biol Ther | 2018 | https://conductscience.org/library/papers/29799306 | PubMed |
| 29159980 | Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusion. | J Cell Mol Med | 2018 | https://conductscience.org/library/papers/29159980 | PubMed |
| 27303736 | Targeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology. | mSphere | 2016 | https://conductscience.org/library/papers/27303736 | PubMed |
| 26201515 | Akt kinase C-terminal modifications control activation loop dephosphorylation and enhance insulin response. | Biochem J | 2015 | https://conductscience.org/library/papers/26201515 | PubMed |
| 24765092 | Balancing Proliferation with Igκ Recombination during B-lymphopoiesis. | Front Immunol | 2014 | https://conductscience.org/library/papers/24765092 | PubMed |
| 24513978 | Src tyrosine kinase signaling antagonizes nuclear localization of FOXO and inhibits its transcription factor activity. | Sci Rep | 2014 | https://conductscience.org/library/papers/24513978 | PubMed |
| 24303055 | In vivo regulation of brain-derived neurotrophic factor in dorsal root ganglia is mediated by nerve growth factor-triggered Akt activation during cystitis. | PLoS One | 2013 | https://conductscience.org/library/papers/24303055 | PubMed |
| 21908616 | IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21908616 | PubMed |
| 20890458 | Activation of mTOR coincides with autophagy during ligation-induced atrophy in the rat submandibular gland. | Cell Death Dis | 2010 | https://conductscience.org/library/papers/20890458 | PubMed |
| 20689057 | Loss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion. | Am J Physiol Gastrointest Liver Physiol | 2010 | https://conductscience.org/library/papers/20689057 | PubMed |
| 20179209 | Protection from rapamycin-induced apoptosis by insulin-like growth factor-I is partially dependent on protein kinase C signaling. | Cancer Res | 2010 | https://conductscience.org/library/papers/20179209 | PubMed |
| 20081374 | Regulation of Akt signaling activation by ubiquitination. | Cell Cycle | 2010 | https://conductscience.org/library/papers/20081374 | PubMed |
| 19945197 | A 4-aminoquinoline derivative that markedly sensitizes tumor cell killing by Akt inhibitors with a minimum cytotoxicity to non-cancer cells. | Eur J Med Chem | 2010 | https://conductscience.org/library/papers/19945197 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8940066
GET https://conductscience.org/api/papers/v1/8940066/cited_by?page=2